These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 1091317

  • 1. Hepatosplenic schistosomiasis mansoni: an immunologic disease.
    Warren KS.
    Bull N Y Acad Med; 1975 Apr; 51(4):545-50. PubMed ID: 1091317
    [No Abstract] [Full Text] [Related]

  • 2. Adoptive transfer of modulation of granuloma formation and hepatosplenic disease in murine schistosomiasis japonica by serum from chronically infected animals.
    Olds GR, Olveda R, Tracy JW, Mahmoud AA.
    J Immunol; 1982 Mar; 128(3):1391-3. PubMed ID: 7057037
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The Schistosoma japonicum egg granuloma.
    Warren KS, Boros DL, Hang LM, Mahmoud AA.
    Am J Pathol; 1975 Aug; 80(2):279-94. PubMed ID: 1163631
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Detection of immune complexes in ascitic fluid of hepatosplenic schistosomiasis.
    Khalil HM, Makled MK, el Sebai MM, el Naggar MK.
    J Egypt Soc Parasitol; 1987 Dec; 17(2):699-705. PubMed ID: 3121767
    [No Abstract] [Full Text] [Related]

  • 7. The kinetics of hepatosplenic schistosomiasis.
    Warren KS.
    Semin Liver Dis; 1984 Nov; 4(4):293-300. PubMed ID: 6395341
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of granuloma modulation in murine schistosomiasis mansoni by enteric exposure to schistosome eggs.
    Weinstock JV, Blum AM, Kassab JT.
    J Immunol; 1985 Jul; 135(1):560-3. PubMed ID: 3998473
    [Abstract] [Full Text] [Related]

  • 10. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease.
    Colley DG, Garcia AA, Lambertucci JR, Parra JC, Katz N, Rocha RS, Gazzinelli G.
    Am J Trop Med Hyg; 1986 Jul; 35(4):793-802. PubMed ID: 3089040
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Suppression splenic T lymphocytes in human hepatosplenic Schistosomiasis mansoni.
    Ellner JJ, Olds GR, Kamel R, Osman GS, el-Kholy A, Mahmoud AA.
    J Immunol; 1980 Jul; 125(1):308-12. PubMed ID: 6966656
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Modulation of Schistosoma mansoni egg-induced granuloma formation. III. Evidence for an anti-idiotypic, I-J-positive, I-J-restricted, soluble T suppressor factor.
    Abe T, Colley DG.
    J Immunol; 1984 Apr; 132(4):2084-8. PubMed ID: 6199422
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tumoricidal macrophages isolated from liver granulomas of Schistosoma mansoni-infected mice.
    Loveless SE, Wellhausen SR, Boros DL, Heppner GH.
    J Immunol; 1982 Jan; 128(1):284-8. PubMed ID: 7054278
    [Abstract] [Full Text] [Related]

  • 19. Hepatosplenic human schistosomiasis; progress and problems.
    Gigase PL.
    Acta Leiden; 1982 Jan; 49():41-53. PubMed ID: 7188156
    [No Abstract] [Full Text] [Related]

  • 20. The role of circulating immune complexes in the glomerular disease of experimental hepatosplenic schistosomiasis.
    Digeon M, Droz D, Noel LH, Riza J, Rieumailhol C, Bach JF, Santoro F, Capron A.
    Clin Exp Immunol; 1979 Mar; 35(3):329-37. PubMed ID: 378479
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.